When COVID comes back after you seemed to recover, the returning virus can usually still spread to other people.1PubMed Central. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy: An Observational Study A rebound is best treated as part of the same infection, with the same precautions, rather than as a harmless leftover.2Centers for Disease Control and Prevention. COVID-19 Rebound After Paxlovid Treatment The most useful clue to whether you’re contagious right now is already in most medicine cabinets: a home rapid test.3Johns Hopkins Bloomberg School of Public Health. COVID Rebound Can Happen Whether or Not You Take Paxlovid
What the Evidence Shows About Spreading Virus During Rebound
Rebound means your test turns positive again, or symptoms return, after you had tested negative or started feeling better. In people who rebounded after Paxlovid, live virus grew in the lab from samples taken after an earlier sample had grown none.4PubMed Central. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy: An Observational Study So the virus had not only left behind genetic fragments but was again able to infect cells.5PubMed Central. Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment In a small group of people with rebound after Paxlovid, virus levels after the rebound were high, and 3 of 7 had live virus up to 16 days after first testing positive.6Oxford Academic (Clinical Infectious Diseases). Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)
This matters more than a positive PCR result. PCR tests detect genetic material, and fragments of dead virus can keep a PCR positive for weeks after you recover, so a returning positive PCR alone can’t tell you whether anyone could catch the virus from you. Scientists get closest to proving infectiousness by trying to grow virus from a swab on cells in a lab.
Finding live virus after an earlier sample grew none rules out the idea that rebound is just a testing glitch. Lab growth isn’t the same as proven spread between people, though, so the finding points to risk without measuring how often rebound passes the virus on.
Rebound also happens in people who took no antiviral at all.7Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals The one untreated rebound measured in a small study had much lower virus levels than rebounds after Paxlovid.8PubMed Central. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir A single small comparison can’t settle whether untreated rebounds are less contagious, so the safe assumption is that any rebound may spread, treated or not.
How to Tell If You’re Contagious Right Now
A home antigen test, the rapid test you swab at home, turns positive only when there is a fairly large amount of virus in your nose. So a positive rapid test during rebound likely goes along with being contagious.9Johns Hopkins Bloomberg School of Public Health. COVID Rebound Can Happen Whether or Not You Take Paxlovid If symptoms come back and your rapid test stays negative, you may be shedding less virus, though a single negative can miss virus that is still rising.10Johns Hopkins Bloomberg School of Public Health. COVID Rebound Can Happen Whether or Not You Take Paxlovid
Symptoms and test results don’t always rise together. In one group, fewer than half of the people whose virus came back also had symptoms return.11PubMed Central. Factors associated with viral rebound among COVID-19 patients receiving oral antivirals That’s why a common mistake is assuming symptoms equal contagiousness. A lingering cough can last after the virus is gone and doesn’t by itself mean you can spread COVID. A positive line, even a faint one, matters more than how you feel, so treat a faint positive as positive when deciding whether to mask or stay home.
Test as soon as symptoms return or you feel a cold coming back after recovering. If that first test is negative but you still feel ill, test again about 48 hours later, since one negative can miss virus that is still rising. Keep testing every day or two until you get a negative, and use that result to decide when to drop extra precautions. Follow the timing and swabbing steps in the kit instructions, because technique and timing affect the result.
A home test isn’t always enough. People with weakened immune systems may want a PCR or a doctor’s advice, because their rebounds can last longer. And if symptoms worsen, such as trouble breathing, the question is medical care, not just testing.
How Long Rebound COVID Stays Contagious
After Paxlovid, rebound typically showed up about 5 days after the first negative test, ranging from 2 to 7 days.12PubMed Central. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir Counted from finishing the antiviral course, the typical gap was also about 5 days.13PubMed Central. Factors associated with viral rebound among COVID-19 patients receiving oral antivirals So the days right after finishing treatment or first testing negative are the window to watch. Counted from diagnosis, rebound typically came around day 9, and the illness typically cleared by about day 16.14Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals Renewed precautions run from the new positive until you test negative again, not from the original diagnosis.
A first negative test right after treatment isn’t an all-clear, because it can come while some virus is still waiting to rebound. Retesting a few days after finishing treatment can catch a rebound without symptoms.
The total contagious time can be longer, too. In treated people, those who rebounded shed live virus for a typical 14 days, compared with 3 days for those who didn’t rebound.15PubMed Central. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy: An Observational Study The virus that returns is not a drug-resistant version in most people; genetic testing found no resistance changes.16Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
What to Do If Your COVID Comes Back
Whether or not you took an antiviral, the risk of spreading COVID during rebound is managed by following current isolation guidance, including masking.17Centers for Disease Control and Prevention. COVID-19 Rebound After Paxlovid Treatment Restart the precautions you used at first, beginning when symptoms return or a test turns positive. Wear a well-fitting mask around others until you test negative again.
At home, sleep and eat apart from others if you can, especially from older or high-risk relatives. Open windows or run air filters in shared spaces to thin out virus in the air. Tell anyone you spent time with in the days before the rebound so they can watch for symptoms and test.
Tell your employer or school that a positive test came back, since many policies treat it like a new positive. Plan on a few extra days away from others, following your workplace’s policy and current guidance, rather than assuming you can work as usual while testing positive.
Extra Paxlovid or other treatments aren’t recommended when rebound is suspected or diagnosed.18PubMed Central. Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir Rebound in people well enough to stay home has been mild, with no hospital stays or deaths reported.19Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals Contact your doctor, though, if you have a weakened immune system or your symptoms get worse.
Does Paxlovid Cause Rebound
Among home test-kit users, rapid tests turned positive again in about 14 in 100 people who took Paxlovid and about 9 in 100 who didn’t.20medRxiv. The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants Symptoms came back in about 19 in 100 people on Paxlovid and 7 in 100 without it.21medRxiv. The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants The groups were small, and the gap may have been chance.22Scripps Research Digital Trials Center. “COVID rebound” is common, even in untreated patients In four of seven studies comparing treated and untreated people, including a randomized trial, rebound rates did not clearly differ.23Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
Other antivirals show rebound too. In over 11,000 people who took Paxlovid, about 5 in 100 tested positive again within a month of finishing.24medRxiv. COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022 Rebound also followed molnupiravir, another COVID pill, and after accounting for age and health the risk was similar to Paxlovid.25medRxiv. COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
The numbers vary so much because how often rebound is reported depends on how it’s defined and how often people are tested.26Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals Studies that test people daily catch brief rebounds that people testing rarely would miss. Some count only returning symptoms and others only positive tests, which gives different totals. A single figure in the news may reflect one definition, not your own chance of rebounding.
Why might Paxlovid leave room for rebound? Computer models suggest it slows virus production so well that it spares cells the virus could still infect.27PubMed Central. An explanation for SARS-CoV-2 rebound after Paxlovid treatment If some virus survives when the five-day course ends, it can start multiplying again in those spared cells.28PubMed Central. An explanation for SARS-CoV-2 rebound after Paxlovid treatment Drugs that stop virus from making copies are also more likely to allow rebound if the treatment course isn’t long enough.29PubMed. Viral Rebound After Antiviral Treatment: A Mathematical Modeling Study of the Role of Antiviral Mechanism of Action
Paxlovid is prescribed to lower the risk of severe illness in people at high risk, a benefit rebound doesn’t erase. If you’re older or have health conditions, ask your doctor about this tradeoff before deciding.
Who Is More Likely to Have a Longer or Harder Rebound
People whose immune system is weakened by illness or by medicines such as transplant drugs or chemotherapy, had higher odds of rebound with or without treatment.30Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals In rare cases in people with weakened immune systems, the virus has developed changes that make Paxlovid and other treatments stop working.31PubMed. Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2 In Paxlovid’s main trial, though, the one resistance change seen appeared in three people, and none were hospitalized or died.32PubMed Central. In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance
If you’re in a higher-risk group, contact your doctor promptly when symptoms return rather than waiting it out. Ask whether a PCR test or longer monitoring makes sense for your situation. Expect that you may stay contagious longer, and keep precautions until you test clearly negative.
Hospital patients are a different situation. Among people already hospitalized with COVID, those whose virus rebounded stayed longer, about 25 days versus 17.33PubMed. Viral rebound and clinical outcomes in hospitalized patients with COVID-19 In that group, about 22 in 100 with rebound died within 30 days, compared with about 10 in 100 without.34PubMed. Viral rebound and clinical outcomes in hospitalized patients with COVID-19 These figures describe very sick inpatients, while rebound in people recovering at home has been mild.35Morbidity and Mortality Weekly Report. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
Can Rebound Mean a New Infection Instead
Rebound usually appears within about a week of finishing treatment or first testing negative.36PubMed Central. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir A positive test many weeks later is more likely a new infection. New cold symptoms with repeated negative COVID tests may be a different virus.
Symptoms returning within days in someone who had just been sick point toward rebound. A fresh exposure followed by symptoms weeks later points toward reinfection. Timing is a clue, not proof, and only a positive test confirms COVID in either case. While you test positive, the precautions are the same whichever it turns out to be. Worsening or prolonged symptoms deserve a doctor’s visit to check for other causes.